Clinical Trial Update: Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder [Phase 4]

View source ↗

Summary

Phase IV long-term maintenance study evaluating aripiprazole for irritability associated with autism spectrum disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Irritability Associated With Autistic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-05-02